4.3 Article

Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease

Waqqas Afif et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Letter Gastroenterology & Hepatology

Comment on 'Predicting the response to infliximab from trough serum levels'

K. Bendtzen et al.

Review Gastroenterology & Hepatology

Biological Therapies for Inflammatory Bowel Diseases

Paul Rutgeerts et al.

GASTROENTEROLOGY (2009)

Review Gastroenterology & Hepatology

Incidence and Clinical Significance of Immunogenicity to Infliximab in Crohn's Disease: A Critical Systematic Review

Andrea Cassinotti et al.

INFLAMMATORY BOWEL DISEASES (2009)

Article Gastroenterology & Hepatology

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial

W. J. Sandborn et al.

Article Gastroenterology & Hepatology

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial

Jean-Frederic Colombel et al.

GASTROENTEROLOGY (2007)

Article Gastroenterology & Hepatology

Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease

Elana A. Maser et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)

Article Medicine, General & Internal

Infliximab maintenance therapy for fistulizing Crohn's disease

BE Sands et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Gastroenterology & Hepatology

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

P Rutgeerts et al.

GASTROENTEROLOGY (2004)

Article Gastroenterology & Hepatology

Incidence and Importance of Antibody Responses to Infliximab After Maintenance or Episodic Treatment in Crohn's Disease

Stephen B. Hanauer et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)

Article Clinical Neurology

Anti-IFN BAb and NAb antibodies - A minireview

K Bendtzen

NEUROLOGY (2003)

Article Medicine, General & Internal

Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease

F Baert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Medicine, General & Internal

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

SB Hanauer et al.

LANCET (2002)